Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorUzel, Mehmet Murat
dc.contributor.authorKarahan, Eyyüp
dc.contributor.authorCanlı, Melek Köroğlu
dc.contributor.authorGüler, Cenap
dc.date.accessioned2022-02-28T11:40:46Z
dc.date.available2022-02-28T11:40:46Z
dc.date.issued2021en_US
dc.identifier.issn1120-6721-1724-6016
dc.identifier.urihttps://doi.org/10.1177/11206721211019569
dc.identifier.urihttps://hdl.handle.net/20.500.12462/12056
dc.description.abstractPurpose: To determine the prognostic characteristics of optical coherence tomography (OCT) parameters by evaluating diabetic macular edema (DME) patients with early dexamethasone (DEX) shift after three doses of intravitreal ranibizumab (RNB) injection. Methods: Fifty-four eyes of 34 patients who had DEX implant after three doses of RNB were included in this retrospective study. Early DEX shift includes patients who received direct DEX implant replacement after three doses of RNB load. Baseline OCT values and factors affecting best corrected visual acuity (BCVA) and central macular thickness (CMT) response were analyzed with logistic regression analyses. Results: The presence of subretinal fluid and hyperreflective spot (HRS) >20 were found to be a negative predictive factor for anatomical response. (p=0.009, p=0.001, respectively) Low initial BCVA creates a positive effect on visual gain.( p=0.041) Giant outer nuclear layer cysts, completely disrupted inner segment-outer segment and HRS>20 have a negative effect on visual gain. (p=0.025, p=0.043, p=0.023, respectively) According to the receiver operating characteristic analysis, the subretinal fluid volume threshold at which >20% reduction in CMT occurs was determined to be 0.85mm3 . (sensitivity 70%, specificity 84% area under the curve 0.817, p=0.021). Conclusion: The presence of high number of HRS and high subretinal fluid volume at the baseline negatively affect prognosis even in patient groups with early DEX shift.en_US
dc.language.isoengen_US
dc.publisherSage Publications Ltden_US
dc.relation.isversionof10.1177/11206721211019569en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectResistan Diabetic Macular Edemaen_US
dc.subjectDexamethasone Implanten_US
dc.subjectEarly Shiften_US
dc.subjectRanibizumab Loaden_US
dc.subjectSubretinal Fluid Volumeen_US
dc.titleThe prognostic role of optical coherence tomography in diabetic macular edema patients undergoing early dexamethasone implant shiften_US
dc.typearticleen_US
dc.relation.journalEuropean Journal of Ophthalmologyen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0002-7420-8934en_US
dc.identifier.volumeEarly Access MAY 2021en_US
dc.identifier.startpage1en_US
dc.identifier.endpage8en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster